Aren't you concerned that Q2 may have had a backlog of patients that isn't sustainable since the annualized rate of revenue was substantially higher?
Prior to reopening the clinic, USNU was a no-growth company with a previous record of annual sales in 2010 of $2.56 million. USNU treated its first patient on April 29, 2014 which means USNU basically only had two months of operations and reported $737,000 in revenue. That's an annualized pace of $4.4 million compared to the $2.0 million rate it was doing before Hurricane Sandy.
As another example, during that record year in 2010, USNU reported revenue in Q2 of $548,000 for a full three months or around 50% less than the monthly revenue of Q2 2014. Perhaps the anticipated operating losses are expected to come from, in part, revenue going forward that won't be as high as Q2.
The most recent 10Q also warns, "It may take additional time to achieve and sustain the level of patient volume that the center was handling prior to the disruption." This is implying that the giant leap in monthly revenue during Q2 wasn't sustainable.
Maybe it's all boilerplate and USNU is on its way to fame and fortune, but I just don't feel comfortable. I originally got excited by the pick, hence my research, and I'll continue to watch it from the sidelines.
The SwingTrade Portfolio is up 42.1% YTD through 8/8/2014, 83.5% in 2013, and 537.4% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=105141243
Recent USNU News
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:35:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 02:22:28 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 12/05/2023 09:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 10:01:57 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM